This letter confirms that the prior-authorization request submitted on behalf of Emeka Okafor (member ID UHC-220197553) for Transcranial Magnetic Stimulation — 36-session course has been approved.
The determination was rendered under Transcranial Magnetic Stimulation for Treatment-Resistant Depression (Optum Behavioral Health Medical Policy BH-005, effective 2026-01-01). All 5 medical-necessity criteria were evaluated against the submitted clinical evidence.
Clinical rationale: Treatment-resistant depression by FDA criteria; psychotherapy attempted; no contraindications; severity validated.
| Code | Display |
|---|---|
| F33.2 | Major depressive disorder, recurrent severe without psychotic features |